+30.4%
GSK vs XYL
-23.4%
+53.8%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | XYL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -2.0% | +0.1% | -1.3% |
| 7D | -1.8% | -5.0% | +3.2% | -0.4% |
| 30D | -2.2% | -13.2% | +11.0% | +1.9% |
| 3M | -1.8% | -3.7% | +1.9% | -0.9% |
| 6M | -10.6% | -17.7% | +7.1% | -5.4% |
| YTD | +4.4% | -21.5% | +25.9% | +10.7% |
| 1Y | +30.4% | -24.5% | +54.9% | +39.6% |
| All | +30.4% | -23.4% | +53.8% | +39.6% |
Cumulative growth
Daily Returns
Daily percentage return beside XYL.
Daily Out/Under-Performance
Portfolio return minus XYL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XYL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded XYL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling